Immupharma Share Discussion Threads

[w1ndjammer] 02/1/2018 19:03

steady rise into results, then if all goes to plan the insties will
start piling in. They will take this upto a number that resembles the Benlysta
buy out. Thats all we have to base the price on lets see ......

WJ.

[njb67] 02/1/2018 18:56

hot

you should send that to Finncap, I am sure they will appreciate your guidance?

[njb67] 02/1/2018 18:53

ELB

I think the only confusion here must be at finncap - perhaps we should send them the Gilead $7:$1 takeover formula so that they can update their estimate?

And to think that they do this for a living.

Dark days indeed....

[realcooltrader] 02/1/2018 18:48

Hmmm...zho...following Simon Cawkwell??

[hottingup] 02/1/2018 18:46

In Mar 2009, HGSi shares (on their 50% stake in lupus drug Benlysta) were $0.45, becoming $3.23 (market cap $528m) early Jul 2009 just before PIII Benlysta results, $12.51 (market cap of $2 billion+) at close on results day late Jul 2009, and $34.49 ($6.46 billion market cap, as there was also some dilution) at peak in Apr 2010 = 76x return over 13 months from peak low to peak high. (Source: Poster 'sicilian_kan', L-S-E, 8/7/2017)


Not bad on a 50% stake in a drug that seems to be less efficaceous and safe, and more expensive to make, than IMM's Lupuzor; and is just one drug, not one drug within an entire platform applicable to at least 12 big market indications, like Lupuzor.

[englishlongbow] 02/1/2018 18:43

Don't forget to change your incontinence pants before bedtime njb67 and try to remember not to put the dirty ones on your head or use them as a hanky. You know how the dementia makes you all confused. There's a good chap.

[njb67] 02/1/2018 18:39

zho

and how many have recently joined ADVFN. You can add stealth wealth to the list too.

top
conservative? - but they are mutliples of tens or hundreds out, surely? Are you saying the brokers took no account of what could happen if the phase 3 studies were a success and the platform proven?

[zho] 02/1/2018 18:27

spmc

>>I haven't posted on any other shares because I don't own any other companies>>

Yeah, right. I must have met hundreds of investors over the last 30 years and not one owned shares in only one company, not one.

So what are the chances of finding 6 posters in one day, all with an interest in just one company, and that company being the same in each case? I'd guess that the probability of that being a chance event was billions to one against.

[lukead] 02/1/2018 18:25

The underneath is a write-up on Immupharma's subsidiary - Ureka

xxxxxxxxxxxxxxxxxxxx

Ureka, a young innovative enterprise created in 2010, has been located at the IECB since last July.

Specializing in peptidomimeticfoldamers, this start-up is now based at the European Institute of Chemistry and Biology (on the campus of the University of Bordeaux) in the immediate proximity of Gilles Guichard’s team, with whom Immupharma (Ureka’s parent company headed by Dr. Robert Zimmer) has been collaborating since 2002 to develop the UrelixTM technology.
In 2010 this collaboration then led to the creation of Ureka, with the aim of transferring the peptide mimetic technology based on urea derivatives into the marketplace, in partnership with the CNRS.
Thanks to its patented technology (UrelixTM), Ureka is able to modify and stabilize natural peptides with an industrial-scale level of efficiency. The young enterprise is now focused on developing a new class of drugs targeted towards several therapeutic areas, including diabetes.
Last October, Ureka, was awarded a grant from the Regional Council of Aquitaine to support its R&D technology transfer in order to accelerate the clinical development of therapeutic compounds for the treatment of diabetes – a great award for this fast growing company that counts four employees, including three researchers.

More information about Ureka:

ImmuPharma to access pioneering research in the Bordeaux region of France

ImmuPharma awarded a grant in support of its pioneering research in the Bordeaux region of France

[michaelamouse] 02/1/2018 18:21

njb, get with it son, keep up with the game, you talk as if you are one grump, heed my advice, and get out more and Remark, speak English, old fruitcake.

[l0ngterm] 02/1/2018 18:15

Fair enough will get back on your other post shortly, out for dinner. So maybe tomorrow.Cheers

[l0ngterm] 02/1/2018 18:11

Zho: you amuse me lol

[topdiesel] 02/1/2018 18:03

zho...I guess everyone in your country works during the day. I am amazed that I have become such a focal point for you. I am to please. I will keep posting in order to give you something to react to. Your narrow mind only allows for possibilities that you can think up. Probably the reason you missed out on this one before it had a 400% increase. Good day sir.

[njb67] 02/1/2018 18:03

mm

are you not worried that the broker is suggesting a target of just 237p

brokers can be wrong of course, but to not predict 20, 40, 200 pounds is a little remiss of them surely?

thank you for your concern.

[zho] 02/1/2018 17:59

topdiesel

>>This is my only stock in London. I am in USA.>>

And your boiler house is open for business at 4am US time? God, they're working you hard.

[divinessence] 02/1/2018 17:58

Strange trading pattern today right from the start. Something afoot me thinks?! Deal/Partnership, bid, takeover, leak or just getting close to results? Whateva exciting times ahead.

[aussieb3] 02/1/2018 17:56

Anyone looking at the chart for last 3 months it's gone pretty much straight up other then the odd day very positive , let's keep going this way

[michaelamouse] 02/1/2018 17:53

oh dear , njb67, not that smart are you ? regarding the brokers note , i.e. 237p plus £5, as i say, even though you are an oldie, get yourself laid and come back a different man. You should really have been buying more, you know
And another really useless remark from the village idiot, Remark ( you may have not noticed but i do have an "a" in my username, old bean).

[runtoma] 02/1/2018 17:48

njb Thats the spirit developing some backbone at last.

[njb67] 02/1/2018 17:43

NY Boy

That is a disappointing target....still think this is worth £5/share if all goes well

njb

[qs99] 02/1/2018 17:41

Lovely finish IMO today, bodes well for more this week. not long to wait now IMO....GLA long term holders.....

[ny boy] 02/1/2018 17:36

Broker Forecast - finnCap issues a broker note on ImmuPharma PLC
12th December 2017, 08:00

finnCap today initiates coverage of ImmuPharma PLC [LON:IMM] with a buy investment rating and price target of 237p.